Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Dogs and rabbits may help dementia patients regain movement — a trial puts it to the test

NCT ID NCT07730983

Symptom relief Sponsor: LNA SANTE Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time

Summary

This randomized trial tests whether adding animal-assisted therapy (AAT) — structured sessions with a trained dog and/or rabbits — to standard rehabilitation can improve motor abilities, independence, and quality of life in older adults with dementia who are hospitalized in a medical rehabilitation unit. Participants will attend eight one-hour sessions over four weeks, with one group receiving standard rehab plus AAT and the other receiving standard rehab alone. The study measures changes in movement, daily living skills, fall risk, and well-being at the end of the program.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Animal-assisted therapy (AAT) with a trained dog and/or rabbits, combined with standard rehabilitation
What this could lead to
If it works, this could point toward a simple, enjoyable way to boost motor recovery and daily independence for people with dementia during rehabilitation.
What could go wrong
This is a small, early-stage trial with only 32 participants, so results may not apply widely. The therapy requires trained animals and staff, which may limit availability.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 32 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Hospitalized in the geriatric medical and rehabilitation ward (SMR) of Institut Médical de Sologne (IMDS) * Diagnosed dementia or confirmed cognitive decline, shown by a score between 15 and 24 on the Mini-Mental State Examination (MMSE - a short standardized test of memory and thinking) * Has active motor rehabilitation goals (identified need to improve movement abilities during hospitalization) * Participant and/or their legal guardian, trusted person (personne de confiance), curator, or family member has provided written consent to participate in the study * Affiliated to a French social security scheme Exclusion Criteria: * Known allergy to the animals used in the animal-assisted therapy sessions (dog, rabbits) * Fear of animals * History of aggressive behavior toward animals * Concomitant psychiatric disorders * Needs only a stimulation and/or skills maintenance approach (no active motor rehabilitation goals) * Currently enrolled in another interventional research study (Note: A participant who was previously enrolled in another interventional study may join RÉMÉDI-A once their participation in the prior study has ended, without a washout period, provided all eligibility criteria are met.)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cognitive dysfunction ( mmse < 24 ) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cognitive disorder Cognitive Dysfunction dementia developmental coordination disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cognitive dysfunction ( mmse < 24 ) Dementia Motor skills disorders

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Institut Médical de Sologne LNA Santé

    Lamotte-Beuvron, 41600, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.